Article info
PDFTest yourself
An elusive cause for a progressive neuropathy
- Correspondence to Dr Martin Turner, Clinical Neurology, West Wing Level 3, John Radcliffe Hospital, Oxford OX3 9DU, UK; martin.turner{at}ndcn.ox.ac.uk
Citation
An elusive cause for a progressive neuropathy
Publication history
- First published July 11, 2013.
Online issue publication
April 14, 2016
Article Versions
- Previous version (14 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features
- Sensory neuronopathies: new genes, new antibodies and new concepts
- Clinical assessment of the sensory ataxias; diagnostic algorithm with illustrative cases
- The dorsal root ganglion under attack: the acquired sensory ganglionopathies
- Double trouble: para-neoplastic anti-PCA-2 and CRMP-5-mediated small fibre neuropathy followed by chorea associated with small cell lung cancer and evolving radiological features
- Paraneoplastic subacute sensory neuronopathy in association with adenocarcinoma of the prostate
- Diagnosis and management of sensory polyneuropathy
- Rare case of anti-CV2 paraneoplastic polyneuropathy associated with lung adenocarcinoma
- Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma
- Paraneoplastic neurological syndromes: a practical approach to diagnosis and management